查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612554

生物晶片市場：按類型、製造技術、應用和最終用戶分類 - 全球預測 2025-2030

Biochips Market by Type (Arrays, DNA Chips, Lab-On-A-Chip), Fabrication Technology (Microarrays, Microfluidics), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物晶片市值為202.9億美元，預計2024年將達到241億美元，複合年成長率為19.44%，到2030年將達到704億美元。

生物晶片是生物技術領域的革命性組件，可作為小型實驗室，可以同時進行數百或數千個生化反應。其範圍超出了診斷、藥物發現、基因組學、蛋白質組學和個人化醫療，以提高效率和精確度。生物晶片因其在篩檢和快速分析方面的高性能和效用而受到越來越多的需求，滿足了對個人化醫療解決方案和簡化藥物開發流程的需求。在世界對健康和永續實踐日益成長的興趣的推動下，它在醫學、農業和環境監測等各個領域都有應用。主要最終用戶包括製藥公司、研究機構和醫療診斷公司。生物晶片市場的成長受到技術進步、研究經費增加以及需要先進診斷工具的慢性病盛行率上升的影響。隨著生物資訊學和人工智慧技術的融合，個人化醫療和就地檢驗有著廣闊的前景。公司可以透過投資多功能生物晶片的研發、提高靈敏度以及尋求與高科技公司合作以獲得尖端解決方案來獲得資金。

主要市場統計
基準年[2023] 202.9億美元
預測年份 [2024] 241億美元
預測年份 [2030] 704億美元
複合年成長率（%） 19.44%

然而，市場並非沒有挑戰。高成本、嚴格的監管要求以及對與生物晶片開發相關的專業知識的需求是主要障礙。此外，資料隱私和生物晶片標準化問題也可能阻礙成長。為了克服這些擔憂，相關人員應專注於具有成本效益的生產技術，並努力建立通用標準。創新在於擴大生物晶片在食品安全和法醫學等非傳統領域的應用，並提高生物相容性和可擴展性以實現更廣泛的採用。競爭格局是動態的，主要參與企業之間不斷進步並加強合作。這些不斷變化的市場動態表明技術創新的巨大潛力，特別是在開發生物晶片技術以滿足不斷成長的全球健康需求方面，從而確保永續的業務成長和市場擴張。

市場動態：揭示快速發展的生物晶片市場的關鍵市場洞察

供需的動態相互作用正在改變生物晶片市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 危及生命的疾病增加，老年人數量增加
    • 癌症治療中個人化醫療的需求不斷成長
    • 就地檢驗的需求增加
  • 市場限制因素
    • 與製造生物晶片產品相關的高成本
  • 市場機會
    • 基因組學和蛋白​​質組學領域的持續進步
    • 私營和公共部門增加對生物技術領域的投資
  • 市場問題
    • 與生物晶片製造和部署相關的嚴格法規

波特五力：駕馭生物晶片市場的策略工具

波特的五力框架是了解生物晶片市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物晶片市場的外部影響

外部宏觀環境因素在塑造生物晶片市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解生物晶片市場的競爭格局

對生物晶片市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：生物晶片市場供應商績效評估

FPNV定位矩陣是評估生物晶片市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製生物晶片市場的成功之路

生物晶片市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 危及生命的疾病發生率不斷上升，老年人口數量不斷增加
      • 癌症治療中個人化醫療的需求不斷成長
      • 就地檢驗的需求增加
    • 抑制因素
      • 與製造生物晶片產品相關的高成本
    • 機會
      • 基因組學和蛋白​​質組學領域的持續進步
      • 私營和公共部門增加對生物技術領域的投資
    • 任務
      • 與生物晶片製造和實施相關的嚴格規定
  • 市場區隔分析
    • 類型：消費者更喜歡使用實驗室晶片進行照護現場診斷，因為它們可以提供快速、準確的結果
    • 製造技術：微流體在病原體檢測的照護現場診斷的廣泛使用
    • 應用：生物晶片在藥物發現中的重要作用，用於化合物識別和標靶檢驗
    • 最終用戶：生物晶片在生物技術和製藥公司的新藥發現和個人化醫療中越來越受歡迎。
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章生物晶片市場：依類型

  • 介紹
  • 大批
    • 帽陣列
    • 組織陣列
  • DNA晶片
  • 實驗室晶片
  • 蛋白質晶片

第7章生物晶片市場：依製造技術分類

  • 介紹
  • 微陣列
  • 微流體

第8章生物晶片市場：依應用分類

  • 介紹
  • 臨床診斷
  • 藥物發現
  • 基因組學和蛋白​​質組學來源

第9章生物晶片市場：依最終用戶分類

  • 介紹
  • 學術研究所
  • 生物技術和製藥公司
  • 醫院和診斷中心

第10章美洲生物晶片市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太生物晶片市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲生物晶片市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Archer 的第一代生物晶片 gFET 設計透過與晶圓代工廠合作夥伴共同製造檢驗
    • Opteev 申請新型多重生物晶片專利
    • Nutcracker Therapeutics 籌集了 1.67 億美元的 C 系列資金籌措，以推進 mRNA 療法和第一個基於生物晶片的製造平台的開發
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • ACROBiosystems Inc.
  • Agilent Technologies, Inc.
  • Archer Materials Limited
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • Cellix Ltd. by Randox Laboratories Ltd.
  • Diagnostic Biochips, Inc
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies, Inc.
  • Horiba, Ltd.
  • Illumina, Inc.
  • Innovative Biochips, LLC
  • LI-COR, Inc.
  • Luminex Corporation by DiaSorin SpA
  • Merck KGaA
  • Micronit BV
  • Nutcracker Therapeutics
  • Opteev
  • PerkinElmer Inc.
  • Phalanx BIoTech Group Inc. by WIN Semiconductors Corp.
  • QIAGEN NV
  • Sphere Fluidics Limited
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-430D42AA0CE3

The Biochips Market was valued at USD 20.29 billion in 2023, expected to reach USD 24.10 billion in 2024, and is projected to grow at a CAGR of 19.44%, to USD 70.40 billion by 2030.

Biochips represent a revolutionary component within biotechnology, serving as miniaturized laboratories capable of performing hundreds or thousands of simultaneous biochemical reactions. Their scope transcends diagnostics, drug discovery, genomics, proteomics, and personalized medicine, enhancing efficiency and precision. Biochips are increasingly necessary due to their utility in high-throughput screening and rapid analysis, which support the demand for personalized healthcare solutions and streamlined drug development processes. They find applications across various sectors including healthcare, agriculture, and environmental monitoring, driven by the rising global focus on health and sustainable practices. Key end-users include pharmaceutical companies, research institutions, and medical diagnostics companies. Market growth for biochips is influenced by technological advancements, increasing funding for research, and rising prevalence of chronic diseases demanding advanced diagnostic tools. There are promising opportunities in personalized medicine and point-of-care testing, driven by the integration of bioinformatics and AI technologies. Businesses can capitalize by investing in R&D for multi-functional biochips, enhancing sensitivity, and exploring partnerships with tech companies for cutting-edge solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 20.29 billion
Estimated Year [2024] USD 24.10 billion
Forecast Year [2030] USD 70.40 billion
CAGR (%) 19.44%

However, the market is not without its challenges. High costs associated with biochip development, stringent regulatory requirements, and the need for specialized knowledge pose significant barriers. Additionally, issues related to data privacy and biochip standardization can hinder growth. To overcome these concerns, stakeholders should focus on cost-effective production techniques and work towards establishing universal standards. Innovation lies in the expansion of biochip applications in non-traditional fields like food safety and forensics, and improving biocompatibility and scalability for broader adoption. The competitive landscape is dynamic, with continuous advancements and increasing collaborations among key players. These evolving market dynamics suggest a significant potential for innovation, particularly in developing biochip technologies that cater to growing global health demands, thereby ensuring sustainable business growth and market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biochips Market

The Biochips Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of life-threatening disorder and rise in geriatric population
    • Growing demand of personalized medicine for the treatment of cancer
    • Increasing Demand for Point-of-care Testing
  • Market Restraints
    • High cost associated with the manufacturing of biochips products
  • Market Opportunities
    • Ongoing advancements in field of genomics and proteomics
    • Rising investments in the field of biotechnology from private & public sectors
  • Market Challenges
    • Stringent regulations associated with the manufacturing and implementation of biochips

Porter's Five Forces: A Strategic Tool for Navigating the Biochips Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biochips Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biochips Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biochips Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biochips Market

A detailed market share analysis in the Biochips Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biochips Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biochips Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biochips Market

A strategic analysis of the Biochips Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biochips Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACROBiosystems Inc., Agilent Technologies, Inc., Archer Materials Limited, Bio-Rad Laboratories, Inc., BioMerieux SA, Cellix Ltd. by Randox Laboratories Ltd., Diagnostic Biochips, Inc, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Horiba, Ltd., Illumina, Inc., Innovative Biochips, LLC, LI-COR, Inc., Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Micronit B.V., Nutcracker Therapeutics, Opteev, PerkinElmer Inc., Phalanx Biotech Group Inc. by WIN Semiconductors Corp., QIAGEN N.V., Sphere Fluidics Limited, Standard BioTools Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Biochips Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Arrays, DNA Chips, Lab-On-A-Chip, and Protein Chips. The Arrays is further studied across Cell Arrays and Tissue Arrays.
  • Based on Fabrication Technology, market is studied across Microarrays and Microfluidics.
  • Based on Application, market is studied across Clinical Diagnostics, Drug Discovery, and Genomics & Proteomics Source.
  • Based on End-User, market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Diagnostics Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of life-threatening disorder and rise in geriatric population
      • 5.1.1.2. Growing demand of personalized medicine for the treatment of cancer
      • 5.1.1.3. Increasing Demand for Point-of-care Testing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the manufacturing of biochips products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in field of genomics and proteomics
      • 5.1.3.2. Rising investments in the field of biotechnology from private & public sectors
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with the manufacturing and implementation of biochips
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Consumer preference for lab-on-a-chip for point-of-care diagnostics as they provide quick and accurate results
    • 5.2.2. Fabrication Technology: Extensive use of microfluidics for point-of-care diagnostics for pathogen detection
    • 5.2.3. Application: Significant role of biochips in drug discovery utilized for compound identification and target validation
    • 5.2.4. End-User: Growing preference for biochips by biotechnology & pharmaceutical companies for drug discovery and personalized medicine
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biochips Market, by Type

  • 6.1. Introduction
  • 6.2. Arrays
    • 6.2.1. Cell Arrays
    • 6.2.2. Tissue Arrays
  • 6.3. DNA Chips
  • 6.4. Lab-On-A-Chip
  • 6.5. Protein Chips

7. Biochips Market, by Fabrication Technology

  • 7.1. Introduction
  • 7.2. Microarrays
  • 7.3. Microfluidics

8. Biochips Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Diagnostics
  • 8.3. Drug Discovery
  • 8.4. Genomics & Proteomics Source

9. Biochips Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biotechnology & Pharmaceutical Companies
  • 9.4. Hospitals & Diagnostics Centers

10. Americas Biochips Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biochips Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biochips Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Archer's First-Generation Biochip gFET Design Validated by Joint Fabrication with a Foundry Partner
    • 13.3.2. Opteev Files Patent for New Multiplex Biochip
    • 13.3.3. Nutcracker Therapeutics Raises $167 Million in Series C Financing to Advance its mRNA Therapeutics and First-of-its-Kind Biochip-based Manufacturing Platform
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACROBiosystems Inc.
  • 3. Agilent Technologies, Inc.
  • 4. Archer Materials Limited
  • 5. Bio-Rad Laboratories, Inc.
  • 6. BioMerieux SA
  • 7. Cellix Ltd. by Randox Laboratories Ltd.
  • 8. Diagnostic Biochips, Inc
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. GE HealthCare Technologies, Inc.
  • 11. Horiba, Ltd.
  • 12. Illumina, Inc.
  • 13. Innovative Biochips, LLC
  • 14. LI-COR, Inc.
  • 15. Luminex Corporation by DiaSorin S.p.A.
  • 16. Merck KGaA
  • 17. Micronit B.V.
  • 18. Nutcracker Therapeutics
  • 19. Opteev
  • 20. PerkinElmer Inc.
  • 21. Phalanx Biotech Group Inc. by WIN Semiconductors Corp.
  • 22. QIAGEN N.V.
  • 23. Sphere Fluidics Limited
  • 24. Standard BioTools Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. BIOCHIPS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOCHIPS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOCHIPS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOCHIPS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOCHIPS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOCHIPS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOCHIPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOCHIPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOCHIPS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOCHIPS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOCHIPS MARKET SIZE, BY CELL ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOCHIPS MARKET SIZE, BY DNA CHIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOCHIPS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOCHIPS MARKET SIZE, BY GENOMICS & PROTEOMICS SOURCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. BIOCHIPS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. BIOCHIPS MARKET, FPNV POSITIONING MATRIX, 2023